KynderMed
There's been no solution to preterm birth - the cause of 1M infant deaths and 2M babies surviving with lifelong disabilities - until now. Light is the solution.
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location St Petersburg, FL, US
- Currency USD
- Founded May 2014
- Employees 1
- Incorporation Type C-corp
- Website kyndermed.com
Company Summary
15 Mil. babies are born too soon each year, called preterm birth. 1 Mil. die and 2 Mil. survive with lifelong disabilities. Our solution is patented safe, light therapy delivered in a sleep mask that prevents preterm contractions. The initial addressable market is 7.7 million annually. Our competition is limited to 3% whereas we can serve over 40% of pregnancies. Demand is strong. Evidence shows we should reach $59M in sales by the 4th year.
Team
-
Executive ChairmanDon has launched 10 times into the same channels and achieved insurance reimbursement. His experience comes from a career in the life science industry with major corporations, consulting firms, and start-ups / spin-outs. He has specific expertise in both Women's Health and Medical Devices. Don has led, advised secured funding, or guided 6 start-ups & all are advancing toward their goals. Don was a commercialization advisor to NIH and WHO.
-
ScientistJames is the inventor of the technology and a leading authority on melatonin. He is a Professor of Biomedical Sciences, Neuroscience and Molecular Biophysics,. He also served as a professor and group leader for The Hormone & Fertility Research Institute at the University of Hamburg Med School in Hamburg, Germany.
With over 100 peer reviewed articles James is an acknowledged expert in circadian rhythms and neuroendocrine mechanisms.
-
Regulatory ConsultantAlan is a regulatory consultant who has the unique distinction of having successfully taken numerous medical devices in both women’s health and light therapy through the FDA approval process, from strategy through approval.
In addition to having run his own consulting firm for 10 years he has served as VP of Regulatory / Clinical Affairs for three early stage companies.
-
Product Development LeadJustin has 15 years experience in Project Management, Systems Engineering and Manufacturing Engineering with Medical Device companies including Smith Nephew, ConMed and Draeger.
-
President & CEOMelanie has 10 years of experience maternal and child health analytics. She has participated in startups developing and bringing new technologies to market, created organizations and served as a financial advisor to investors. She was a first angel investor in Kyndermed. She is a published researcher in the field and, as a result, she knew the enormous need and size of the opportunity.
Advisors
-
Doug TatumChairman, Newport Board GroupUnconfirmedInvestor and Consultant
David SeiferPartner, Stearns WeaverUnconfirmed -
Entrepreneur in Residence, Florida Institute for the Commercialization of Public Research
Professor Reproductive Sciences, University of Toronto, Medical Director, Toronto Centre for Advanced Reproductive Technology, and Senior Investigator, Lunnenfeld-Tannenabum Research Institute, Mount Sinai Hospital
Previous Investors
-
Florida Institute for the Commercialization of Public ResearchUnconfirmed
Johnson Magrath PartnersUnconfirmed
Florida Angel NexusUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.